Impact of predicted microbiota tryptophanase activity on Cryptosporidium parvum proliferation

Debora Regina Romualdo da Silva1,2, Xiaojiao Yang3, Giovanni Widmer1

  • 1Cummings School of Veterinary Medicine at Tufts University, Department of Infectious Diseases & Global Health, North Grafton, Massachusetts, United States of America.

Plos One
|June 13, 2025
PubMed

Insights

Investigating the gut microbiota

Area of Science:

  • Microbiology
  • Immunology
  • Gastroenterology

Background:

  • Cryptosporidium parvum infects intestinal cells, and its proliferation is influenced by gut microbiota.
  • Mechanisms of this interaction and potential probiotic interventions remain largely unknown.
  • Lack of effective treatments necessitates exploring strategies like probiotics for cryptosporidiosis.

Purpose of the Study:

  • To investigate if oral administration of Escherichia coli affects Cryptosporidium parvum proliferation in mice.
  • To explore the role of the gut microbiota and indole production in cryptosporidiosis.

Main Methods:

  • Oral administration of ampicillin-resistant, GFP-expressing E. coli to mice.
  • Quantification of fecal E. coli and C. parvum output.
  • Analysis of pre-infection microbiota composition and indole production potential.

Main Results:

  • A positive correlation was observed between fecal E. coli and C. parvum output.
  • Pre-infection microbiota profiles predicted susceptibility to C. parvum.
  • Indole production potential correlated positively with C. parvum output, contrary to expectations.
  • Cryptosporidiosis led to an expansion of facultative anaerobes, notably Gammaproteobacteria.

Conclusions:

  • Gut microbiota composition influences C. parvum susceptibility.
  • E. coli administration did not inhibit, but rather correlated with, C. parvum proliferation in this model.
  • This study provides initial insights into the complex interplay between a defined probiotic, the gut microbiota, and C. parvum infection.